Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
China Pushes Generic Drug Policy to Undermine MNCs amid Threat of Trade War
Chief Editor James Shen offers his monthly review of the Chinese healthcare sector with this issue's emphasis on new government policy to support generic drugs and import... (4/30/2018)
   
What Chinese Consumers Want From Western Retailers (5/23/2018)
New Challenges Ahead: How To Comply With Cross-Border Data Transfer Regulation In China (5/17/2018)
Trump's 'America First' Agenda on Drug Pricing Could Trigger Impacts Around the World (5/10/2018)
USN: China's Lock on Drugs (5/9/2018)
The China Drug Administration Proposes a Working Procedure for Pharmaceutical Study Data Protection (5/9/2018)
Eisai Gives Chinese Doctors and Patients Upper Hand against Cancer, Serious Illnesses (4/30/2018)
China Pushes Generic Drug Policy to Undermine MNCs amid Threat of Trade War (4/30/2018)
As India, China Drug Industries Mature, FDA Scrutiny an Overhang (4/26/2018)
China to Test Data Monitoring System for Hospital Outpatients under Trial Scheme This Year (4/26/2018)
Gibson: U.S.'s Growing Dependence on China For Vital Medicines A National Security Risk (4/24/2018)
The Biosimilar Race in China (4/24/2018)
Breaking News on New Policies of Innovative Drugs in China (4/19/2018)
Chinese Money Floods U.S. Biotech as Beijing Chases New Cures (4/18/2018)
China Announces New Initiatives to Level the Playing Field for Innovative and Generic Drugs (4/18/2018)
U.S. Businesses Worried over Chinese Policy Initiative (4/17/2018)
Karyopharm and Antengene Sign Exclusive ...  (5/24/2018)
China Approves XiAn Janssen's INVEGA SUS...  (5/24/2018)
WuXi Biologics to Invest to Build a S$80...  (5/23/2018) (free)
CNDA and NHC issue Joint Announcement fo...  (5/23/2018)
A-Share Listed Domestic Pharma Companies...  (5/23/2018)
Pfizer's Chinese Urban Hospital Drug Sal...  (5/23/2018)
MOHRSS Publishes 2017 Human Resources an...  (5/22/2018)
Five Chinese Agencies Jointly Issue 1st ...  (5/22/2018)
CFDA Releases Generic Drug Quality and E...  (5/22/2018)
Takeda Sells Majority Stake in JV Techpo...  (5/22/2018)
Bioasis and WuXi Biologics Enter Strateg...  (5/22/2018)
China May Scrap Its Two-child Family Pla...  (5/22/2018)
Salubris Pharma, MedAllliance Enter Inve...  (5/22/2018)
SAMR Announces Major Initiative to Condu...  (5/20/2018)
Fosun Eyes $2B Acquisition of Low-end No...  (5/20/2018)
CANbridge Receives IND Approval to Commence CAN008 Phase...
Global Contract Pharmaceutical Manufacturing Market to R...
White House Task Force Echoes Pharma Proposals
Pharma Industry Reputation Rebounds Somewhat in 2016
Fresenius Steps Up Pharma M&A with Akorn, Merck KGaA...
Chinese OTC Cough, Cold and Allergy Market Posted 6% Growth in ...
Data Snapshot: Chinese Generic Drug Market
CPIIC: Chinese Rep Hospital Drug Sales Growth Fell Sharply in 2...
Snapshot of Chinese Pharmaceutical CRO Market
SMEI: Urban Pubic Hospital Vaccine Consumption Up Sharply in Re...
Karyopharm and Antengene Sign Exclusive License Agreement fo...
China Approves XiAn Janssen's INVEGA SUSTENNA
WuXi Biologics to Invest to Build a S$80M Manufacturing Faci...
A-Share Listed Domestic Pharma Companies Report Q1/2018 Perf...
Pfizer's Chinese Urban Hospital Drug Sales Rebounded in 2017...
CNDA and NHC issue Joint Announcement for Optimization o...
CFDA Releases Generic Drug Quality and Efficacy Equivale...
CNDA Issues New Reg for Confidentiality Management of Dr...
CDE Solicits Applicant Feedbacks on Implementation of IC...
CNDA to Strengthen Onsite Inspections for Applications o...
SAMR Announces Major Initiative to Conduct Inspection over U...
IP Concerns Hamper China R&D
China to Restructure and Consolidate IP Regulatory Authoriti...
Amended Patent Law Draft to Be Submitted for NPC Deliberatio...
Novartis Entangled in New Bribery Allegation, Days After Its...
WuXi STA Changzhou Site Passes First U.S. FDA Inspection...
FDA Warns Chinese API Producer for Data Integrity and Ot...
Trump's China Tariff Plan Target Dozens of Key APIs and ...
Stada: Pollution Crackdown in China Led to Pharma Supply...
India to Blacklist Eight Chinese Pharma Companies for Qu...
Innovent Announces Result of its Anti-PD-1 Antibody Stud...
Cstone Announces First Patient Dosed with Anti-CTLA-4 An...
HKU Scientists Invent Universal Antibody Drug against HI...
UCB Announces Filing Acceptance with the CNDA for RA Dru...
MSD's HPV Vaccine Gardasil 9 under Review in China
MOHRSS Publishes 2017 Human Resources and Social Securit...
Five Chinese Agencies Jointly Issue 1st Batch of Rare Di...
China May Scrap Its Two-child Family Planning Policy
NHC Issues Notice to Sustain Control of Antibiotic Clini...
The Lancet - Cancer Drugs in China: Affordability and Cr...
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
Upcoming Event: International Conference on Diabetes and...
Upcoming Event: World Pharmacology 2018
Upcoming Event: International Conference on Pharmacology...
Upcoming Event: The 3rd Annual Biopharma Innovation Conf...
NHC Minister Meets Merieux Foundation Delegation
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
  WiCON and PharmaGuys Launch Ph...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links